Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Advaxis stock

Learn how to easily invest in Advaxis stock.

Advaxis Inc is a biotechnology business based in the US. Advaxis shares (ADXS) are listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and all prices are listed in US Dollars. Advaxis employs 14 staff and has a trailing 12-month revenue of around $500,000.

How to buy shares in Advaxis

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADXS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Advaxis stock price (OTCQX: ADXS)

Use our graph to track the performance of ADXS stocks over time.

Advaxis shares at a glance

Information last updated 2022-07-08.
Latest market close$4.06
52-week range$0.06 - $0.56
50-day moving average $4.75
200-day moving average $16.80
Wall St. target price$2.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.10

Buy Advaxis shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Advaxis stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Advaxis price performance over time

Historical closes compared with the close of $4.06 from 2022-07-07

1 week (2022-09-20) N/A
1 month (2022-08-28) N/A
3 months (2022-07-01) 14.37%
6 months (2022-03-30) 3,274.90%
1 year (2021-09-27) 686.82%
2 years (2020-10-01) 925.25%
3 years (2019-10-01) 1,447.26%
5 years (2017-09-29) 4.18

Advaxis financials

Revenue TTM $500,000
Gross profit TTM $3.2 million
Return on assets TTM -20.79%
Return on equity TTM -28.01%
Profit margin 0%
Book value $19.31
Market capitalisation $112,869

TTM: trailing 12 months

Advaxis share dividends

We're not expecting Advaxis to pay a dividend over the next 12 months.

Have Advaxis's shares ever split?

Advaxis's shares were split on a 1:80 basis on 5 June 2022. So if you had owned 80 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Advaxis shares – just the quantity. However, indirectly, the new 7900% higher share price could have impacted the market appetite for Advaxis shares which in turn could have impacted Advaxis's share price.

Advaxis share price volatility

Over the last 12 months, Advaxis's shares have ranged in value from as little as $0.055 up to $0.56. A popular way to gauge a stock's volatility is its "beta".

ADXS.US volatility(beta: 2.21)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (OTCQX average) beta is 1, while Advaxis's is 2.2077. This would suggest that Advaxis's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Advaxis overview

Advaxis, Inc. , a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co. , Inc. ; OS Therapies, LLC; Aratana Therapeutics Inc.

Frequently asked questions

What percentage of Advaxis is owned by insiders or institutions?
Currently 0.048% of Advaxis shares are held by insiders and 1.467% by institutions.
How many people work for Advaxis?
Latest data suggests 14 work at Advaxis.
When does the fiscal year end for Advaxis?
Advaxis's fiscal year ends in October.
Where is Advaxis based?
Advaxis's address is: 9 Deer Park Drive, Monmouth Junction, NJ, United States, 08852
What is Advaxis's ISIN number?
Advaxis's international securities identification number is: US0076243072
What is Advaxis's CUSIP number?
Advaxis's Committee on Uniform Securities Identification Procedures number is: 007624109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site